{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:12:20Z","timestamp":1784121140800,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002558","name":"Warren Alpert Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS098243"],"award-info":[{"award-number":["NS098243"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM151124"],"award-info":[{"award-number":["GM151124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA241105"],"award-info":[{"award-number":["CA241105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3\/28\/2019"],"award-info":[{"award-number":["3\/28\/2019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.nbd.2024.106674","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T02:22:55Z","timestamp":1726626175000},"page":"106674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prion protein pathology in Ubiquilin 2 models of ALS"],"prefix":"10.1016","volume":"201","author":[{"given":"Nhat T.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole R.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouada","family":"Nebie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyi","family":"Adelakun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Butts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn J.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2024.106674_bb0005","doi-asserted-by":"crossref","first-page":"21743","DOI":"10.1073\/pnas.1010243107","article-title":"Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly","volume":"107","author":"Aitio","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106674_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2014.00045","article-title":"Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity","volume":"2","author":"Black","year":"2014","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.nbd.2024.106674_bb0015","article-title":"Defective proteasome delivery of Polyubiquitinated proteins by Ubiquilin-2 proteins containing ALS mutations","volume":"10","author":"Chang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2024.106674_bb0020","doi-asserted-by":"crossref","first-page":"26377","DOI":"10.1074\/jbc.M110.145516","article-title":"Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues","volume":"285","author":"Chen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2024.106674_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106674_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060971","article-title":"Induced pluripotent stem cells and their applications in amyotrophic lateral sclerosis","volume":"12","author":"Du","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2024.106674_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jnnp-2013-306112","article-title":"Surgery and amyotrophic lateral sclerosis: avoid the surgeon","volume":"85","author":"Eisen","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106674_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005623","article-title":"A neuronal culture system to detect prion Synaptotoxicity","volume":"12","author":"Fang","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2024.106674_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007283","article-title":"Prions activate a p38 MAPK synaptotoxic signaling pathway","volume":"14","author":"Fang","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2024.106674_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(00)00084-2","article-title":"Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP","volume":"28","author":"Feng","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2024.106674_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/cpcb.51","article-title":"Transcription factor-mediated differentiation of human iPSCs into neurons","volume":"79","author":"Fernandopulle","year":"2018","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.nbd.2024.106674_bb0060","doi-asserted-by":"crossref","first-page":"37968","DOI":"10.1038\/srep37968","article-title":"Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis","volume":"6","author":"Fogarty","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106674_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-016-0347-y","article-title":"Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"4","author":"Fogarty","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2024.106674_bb0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00012.2016","article-title":"Ubiquitination and the regulation of membrane proteins","volume":"97","author":"Foot","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2024.106674_bb0075","doi-asserted-by":"crossref","first-page":"1000183","DOI":"10.3389\/fnmol.2022.1000183","article-title":"Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease","volume":"15","author":"Gelon","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2024.106674_bb0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00401-019-02053-5","article-title":"Abeta-induced acceleration of Alzheimer-related tau-pathology spreading and its association with prion protein","volume":"138","author":"Gomes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2024.106674_bb0085","first-page":"3552","article-title":"Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane","volume":"126","author":"Goold","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2024.106674_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mcn.2014.12.009","article-title":"Prion degradation pathways: potential for therapeutic intervention","volume":"66","author":"Goold","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2024.106674_bb0095","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1471-4159.2006.03837.x","article-title":"Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells","volume":"97","author":"Grenier","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2024.106674_bb0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0014-4886(79)90129-8","article-title":"Degeneration of the human Betz cell due to amyotrophic lateral sclerosis","volume":"63","author":"Hammer","year":"1979","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2024.106674_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12948","article-title":"Serpin neuropathology in the P497S UBQLN2 mouse model of ALS\/FTD","volume":"31","author":"Higgins","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2024.106674_bb0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.410160306","article-title":"Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies","volume":"16","author":"Horoupian","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2024.106674_bb0115","first-page":"65","article-title":"Human spinal cord neurons in culture as a tool to study amyotrophic lateral sclerosis","volume":"209","author":"Kato","year":"1987","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2024.106674_bb0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S1355617709990944","article-title":"Categorical spatial memory in patients with mild cognitive impairment and Alzheimer dementia: positional versus object-location recall","volume":"16","author":"Kessels","year":"2010","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.nbd.2024.106674_bb0125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2024.106674_bb0130","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/nen.0b013e318093ecc7","article-title":"Involvement of the endosomal-lysosomal system correlates with regional pathology in Creutzfeldt-Jakob disease","volume":"66","author":"Kovacs","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2024.106674_bb0135","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106674_bb0140","doi-asserted-by":"crossref","first-page":"E7580","DOI":"10.1073\/pnas.1608432113","article-title":"Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations","volume":"113","author":"Le","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106674_bb0145","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1111\/febs.16129","article-title":"UBQLN proteins in health and disease with a focus on UBQLN2 in ALS\/FTD","volume":"289","author":"Lin","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2024.106674_bb0150","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1523\/JNEUROSCI.2313-05.2005","article-title":"Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways","volume":"25","author":"Lopes","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2024.106674_bb0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbrc.2020.02.102","article-title":"Prion protein interacts with the metabotropic glutamate receptor 1 and regulates the organization of ca(2+) signaling","volume":"525","author":"Matsubara","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2024.106674_bb0160","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1523\/JNEUROSCI.23-18-07183.2003","article-title":"Cytosolic prion protein in neurons","volume":"23","author":"Mironov","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2024.106674_bb0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/excr.1996.0100","article-title":"Resolution of kinase activities during the HeLa cell cycle: identification of kinases with cyclic activities","volume":"223","author":"Monteiro","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.nbd.2024.106674_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2022.130284","article-title":"UBQLN2 undergoes a reversible temperature-induced conformational switch that regulates binding with HSPA1B: ALS\/FTD mutations cripple the switch but do not destroy HSPA1B binding","volume":"1867","author":"Phung","year":"2023","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.nbd.2024.106674_bb0175","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1675487","article-title":"Molecular biology of prion diseases","volume":"252","author":"Prusiner","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.nbd.2024.106674_bb0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.ne.17.030194.001523","article-title":"Prion diseases and neurodegeneration","volume":"17","author":"Prusiner","year":"1994","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2024.106674_bb0185","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nsmb962","article-title":"Diverse polyubiquitin interaction properties of ubiquitin-associated domains","volume":"12","author":"Raasi","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.nbd.2024.106674_bb0190","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/emboj.2011.86","article-title":"The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication","volume":"30","author":"Resenberger","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2024.106674_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/v13081625","article-title":"The cellular prion protein increases the uptake and toxicity of TDP-43 fibrils","volume":"13","author":"Scialo","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.nbd.2024.106674_bb0200","doi-asserted-by":"crossref","first-page":"21658","DOI":"10.1038\/srep21658","article-title":"Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells","volume":"6","author":"Shim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106674_bb0205","series-title":"Controlling homology-directed repair outcomes in human stem cells with dCas9. bioRxiv, in press., 2021.2012.2016.472942","author":"Skarnes","year":"2021"},{"issue":"53","key":"10.1016\/j.nbd.2024.106674_bb0210","first-page":"e2794","article-title":"Analysis of dendritic spine morphology in cultured CNS neurons","author":"Srivastava","year":"2011","journal-title":"J. Vis. Exp: JoVE"},{"key":"10.1016\/j.nbd.2024.106674_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.681029","article-title":"Editorial: synaptic loss and neurodegeneration","volume":"15","author":"Subramanian","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2024.106674_bb0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00686086","article-title":"Degeneration of Betz cells in motor neuron disease. A Golgi study","volume":"70","author":"Udaka","year":"1986","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2024.106674_bb0225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/19336896.2017.1334748","article-title":"The cellular prion protein (PrP(C)) as neuronal receptor for alpha-synuclein","volume":"11","author":"Urrea","year":"2017","journal-title":"Prion"},{"key":"10.1016\/j.nbd.2024.106674_bb0230","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1002\/jcb.24234","article-title":"Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis","volume":"113","author":"van Zundert","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.nbd.2024.106674_bb0235","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/brain\/awn071","article-title":"Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis","volume":"131","author":"Vucic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2024.106674_bb0240","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.stemcr.2017.08.019","article-title":"Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening","volume":"9","author":"Wang","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.nbd.2024.106674_bb0245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23473","article-title":"The N-terminus of the prion protein is a toxic effector regulated by the C-terminus","volume":"6","author":"Wu","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2024.106674_bb0250","doi-asserted-by":"crossref","first-page":"15230","DOI":"10.1073\/pnas.1917371117","article-title":"ALS\/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function","volume":"117","author":"Wu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106674_bb0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12915-017-0375-5","article-title":"The biological function of the cellular prion protein: an update","volume":"15","author":"Wulf","year":"2017","journal-title":"BMC Biol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:01:19Z","timestamp":1778792479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996124002742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"alternative-id":["S0969996124002742"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106674","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prion protein pathology in Ubiquilin 2 models of ALS","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106674"}}